Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients ...

Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in ...

NeurIPS, the biggest AI research conference, turned Vancouver’s convention center into a battleground for wooing AI talent.

Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...

“The GeparOla trial included patients with early HER2-negative breast cancer who had homologous recombination deficiency, HRD ...

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

Consistent daily patching in the first year after surgery improved visual acuity in children with a congenital cataract in ...

The following is a summary of “Evaluating Digital Rehabilitation Outcomes in Chronic Musculoskeletal Conditions Across Non-Obesity, Obesity, and Severe Obesity,” published in the January 2025 issue of ...

Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with ...

The human Stone Age was, undeniably, the first step on a journey towards the species total technological dominance – but it ...

One year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to ShingrixSEATTLE, ...

With high biologic treatment failure rates common among patients who have hidradenitis suppurativa (HS), investigators set ...